Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02320981 · ClinicalTrials.gov registry record
Mucosal Impedance in Pediatric Population
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 127
- Enrollment target
NCT02320981: Completed study, sponsored by Vanderbilt University Medical Center.
NCT02320981 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 127 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02320981 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
Our hypothesis is that patients with GERD and/or Eosinophilic Esophagitis (EE) have lower esophageal impedance measurements when compared to patients who do not have GERD or EE.
Primary Outcome
Mucosal impedance will be obtained during standard of care endoscopy and results will be available immediately. For those patients who may be undergoing ph monitoring as standard of care, those data will be compared to the mucosal impedance values obtained at bedside.
Interventions
- DIAGNOSTIC_TEST Standard of Care esophagogastroduodenoscopy (EGD) with measurement of mucosal impedance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-09 |
What the finished NCT02320981 record still lists
NCT02320981 is an observational study that tracks outcomes without assigning an intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Standard of Care esophagogastroduodenoscopy (EGD) with measurement of mucosal impedance is the first listed.
NCT02320981 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02320981 about?
NCT02320981 is a clinical study titled "Mucosal Impedance in Pediatric Population". Our hypothesis is that patients with GERD and/or Eosinophilic Esophagitis (EE) have lower esophageal impedance measurements when compared to patients who do not have GERD or EE.
What is the current status of trial NCT02320981?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2014-08. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02320981?
The interventions under investigation include: Standard of Care esophagogastroduodenoscopy (EGD) with measurement of mucosal impedance (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02320981?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia